In vitro propagation of parvovirus B19 in primary foetal liver culture

References

1. Anderson M. J., Jones S. E., Fisher-Hoch S. P., Lewis E., Hall S. M., Bartlett C. L. R., Cohen B. J., Mortimer P. P., Pereira M. S. 1983; Human parvovirus, the cause of erythema infectiosum (fifth disease)?. Lancet i:1378
   [Google Scholar]
2. Beard C., St Amand J., Astell C. R. 1989; Transient expression of B19 parvovirus gene products in COS-7 cells transfected with B19-SV40 hybrid vectors. Virology 172:659–664
   [Google Scholar]
3. Brown C. S., Salimans M. M. M., Noteborn M. H. M., Weiland H. T. 1990; Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Research 15:197–211
   [Google Scholar]
4. Brown K. E. 1989; What threat is human parvovirus B19 to the foetus? A review. British Journal of Obstetrics and Gynaecology 96:764–767
   [Google Scholar]
5. Cohen B. J., Mortimer P. P., Pereira M. S. 1983; Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). Journal of Hygiene 91:113–130
   [Google Scholar]
6. Cossart Y. E., Field A. M., Cant B., Widdows D. 1975; Parvovirus-like particles in human sera. Lancet i:72–73
   [Google Scholar]
7. Fridell E., Trojnar J., Wahren B. 1989; A new peptide for human parvovirus B19 antibody detection. Scandinavian Journal of Infectious Diseases 21:597–603
   [Google Scholar]
8. Kajigaya S., Shimada T., Fujita S., Young N. S. 1989; A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proceedings of the National Academy of Sciences, U.S.A. 86:7601–7605
   [Google Scholar]
9. Kurtzman G. J., Ozawa K., Cohen B., Hanson G., Oseas R., Young N. S. 1987; Chronic bone marrow failure due to peristent B19 parvovirus infection. New England Journal of Medicine 317:287–294
   [Google Scholar]
10. Lyon D. J., Chapman C. S., Martin C., Brown K. E., Clewley J. P., Flower A. J. E., Mitchell V. E. 1989; Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Lancet i:1085
    [Google Scholar]
11. Mori J., Field A. M., Clewley J. P., Cohen B. J. 1989; Dot blot hybridization assay of B19 virus DNA in clinical specimens. Journal of Clinical Microbiology 27:459–464
    [Google Scholar]
12. Mortimer P. P., Humphries R. K., Moore J. G., Purcell R. H., Young N. S. 1983; A human parvovirus-like virus inhibits haematopoietic colony formation in vitro . Nature, London 302:426–429
    [Google Scholar]
13. Ozawa K., Kurtzman G., Young N. 1987; Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro . Blood 70:384–391
    [Google Scholar]
14. Pattison J. R., Jones S. E., Hodgson J., Davis L. R., White J. M., Stroud C. E., Murtara L. 1981; Parvovirus infections and hypoplastic crisis in sickle cell anaemia. Lancet i:664–665
    [Google Scholar]
15. Russell E. S., Smith L. J., Lawson F. A. 1956; Implantation of normal blood-forming tissue in radiated genetically anaemic hosts. Science 124:1076–1077
    [Google Scholar]
16. Sisk W. P., Berman M. L. 1987; Expression of human parvovirus B19 structural protein in E. coli and detection of antiviral antibodies in human serum. Bio/Technology 5:1077–1080
    [Google Scholar]
17. Takahashi T., Ozawa K., Takahashi K., Asano S., Takaku F. 1990; Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 75:603–610
    [Google Scholar]
18. Wintrobe M. M., Lee G. R., Boggs D. R., Bithell T. C., Foerster J., Athens J. W., Lukens J. N. 1981; Origin and development of the blood and blood forming tissues. In Clinical Hematology pp 35–74 Philadelphia: Lea and Febiger;
    [Google Scholar]
19. Yaegashi N., Shiraishi H., Takeshita T., Nakamura M., Yajima A., Sugamura K. 1989; Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. Journal of Virology 63:2422–2426
    [Google Scholar]
20. Young N., Harrison M., Moore J., Mortimer P., Humphries R. K. 1984; Direct demonstration of the human parvovirus in erythroid progenitor cells infected in in vitro . Journal of Clinical Investigation 74:2024–2032
    [Google Scholar]